The hemsphere tribune: Updates and insights on r-ATG in BMT

Individualizing rabbit anti-thymocyte globulin (r-ATG) exposure in every patient may be the key to overcoming the drawbacks of current weight-based r-ATG dosing strategies. Emerging clinical outcomes from attempts at individualizing r-ATG dose based on ALC ± weight-guided r-ATG exposure are quite encouraging and lend credence to further evaluation attempts in the form of large-scale RCTs.